Lucy Scientific Discovery, Inc. Overview
Industry: Drug Manufacturers Specialty & Generic
Sector: Healthcare
Lucy Scientific Discovery Inc. engages in the research, development, manufacture, and sale of psychedelic products. It offers biological raw materials, active pharmaceutical ingredients, and finished biopharmaceutical products. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. The company was incorporated in 2017 and is headquartered in Victoria, Canada.
Lucy Scientific Discovery, Inc. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Lucy Scientific Discovery, Inc. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Lucy Scientific Discovery, Inc. Competitors
Lucy Scientific Discovery, Inc. operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans